Welcome to the Brand X newsroom
Read the latest developments in Brand X research, clinical use, company announcements, and other topics relevant to prescribers.
Study shows Brand X effective for elderly hypertensive patients
13/11/2023
New clinical trial data in 278 elderly patients demonstrates Brand X produces significant blood pressure reduction comparable to younger study populations.
ASA: Brand X shows sustained BP control at 5 years
09/11/2023
Poster presentation at the American Society of Hypertension conference reports new long-term data from open-label study showing durable efficacy.
Interview with Brand X clinical trial investigator
07/11/2023
Dr. Linda Park discusses Brand X's 24-hour blood pressure lowering effects, favorable side effect profile, and use in combination therapy.
Brand X approved for pediatric hypertension
27/10/2023
FDA expands approval for Brand X to include treatment of hypertension in pediatric patients ages 6-17 based on trial data.
Hypertension study using Brand X published in JAMA
18/10/2023
The HYPERTrial published results in JAMA demonstrating significant improvements in blood pressure control with Brand X versus placebo.
Tips for improving adherence with Brand X regimens
13/10/2023
Cardiologist Dr. James Able provides best practices for initiating Brand X therapy and encouraging patient adherence long-term.